EUVIMEDEUVIMED entdecken
Crossref

Formulation and Optimization of Novel Liposomal Formulation of Quetiapine Fumarate Intranasal Drug Delivery Using Box Behnken Design Approach

Bhargav Chandegra, Rajnikant Suthar, Jigar Raval, Prajesh Prajapati

Journal of Pharmaceutical Innovation · 2026-08 · 21 (4)

DOI: 10.1007/s12247-026-10582-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 19.03.2026. Verfasst von Bhargav Chandegra und 3 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chandegra, B., Suthar, R., Raval, J., & Prajapati, P. (2026). Formulation and Optimization of Novel Liposomal Formulation of Quetiapine Fumarate Intranasal Drug Delivery Using Box Behnken Design Approach. Journal of Pharmaceutical Innovation, 21(4). https://doi.org/10.1007/s12247-026-10582-2

Vancouver

Chandegra B, Suthar R, Raval J, Prajapati P. Formulation and Optimization of Novel Liposomal Formulation of Quetiapine Fumarate Intranasal Drug Delivery Using Box Behnken Design Approach. Journal of Pharmaceutical Innovation. 2026;21(4). doi:10.1007/s12247-026-10582-2

BibTeX
@article{Chandegra2026,
  author = {Chandegra, Bhargav and Suthar, Rajnikant and Raval, Jigar and Prajapati, Prajesh},
  title = {Formulation and Optimization of Novel Liposomal Formulation of Quetiapine Fumarate Intranasal Drug Delivery Using Box Behnken Design Approach},
  journal = {Journal of Pharmaceutical Innovation},
  year = {2026},
  volume = {21},
  number = {4},
  doi = {10.1007/s12247-026-10582-2}
}
Kostenlos starten →